Revenue: The sum of all revenue fields included for a company's operating activities.
West Pharmaceutical Services, Inc. (WST) had Revenue of $698.00M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$698.00M |
$89.80M |
|
$466.10M |
|
$231.90M |
|
$591.00M |
|
$107.00M |
|
$3.50M |
|
$110.50M |
|
$110.50M |
|
$86.40M |
|
$89.80M |
|
$89.80M |
|
$86.40M |
|
$107.00M |
|
$147.00M |
|
72.50M |
|
73.00M |
|
$1.24 |
|
$1.23 |
|
| Balance Sheet Financials | |
$1.46B |
|
$1.63B |
|
$2.16B |
|
$3.62B |
|
$526.70M |
|
$202.60M |
|
$408.40M |
|
$935.10M |
|
$2.68B |
|
$2.57B |
|
$2.68B |
|
71.80M |
|
| Cash Flow Statement Financials | |
$129.40M |
|
$-71.30M |
|
$-147.00M |
|
$484.60M |
|
$404.20M |
|
$-80.40M |
|
$1.30M |
|
$-15.20M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.77 |
|
-- |
|
-- |
|
0.07 |
|
0.08 |
|
33.22% |
|
15.33% |
|
15.33% |
|
-- |
|
15.83% |
|
12.87% |
|
$58.10M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
1.20 |
|
1.28 |
|
70.09 |
|
3.35% |
|
3.50% |
|
2.48% |
|
3.11% |
|
$37.37 |
|
$0.80 |
|
$1.77 |
|